[English] 日本語
Yorodumi
- PDB-8t74: Crystal structure of KRAS4a (GMPPNP) in complex with RAF1 (RBD) -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 8t74
TitleCrystal structure of KRAS4a (GMPPNP) in complex with RAF1 (RBD)
Components
  • GTPase KRas
  • RAF proto-oncogene serine/threonine-protein kinase
KeywordsONCOPROTEIN / RAS / KRAS / RAF1 / CRAF
Function / homology
Function and homology information


death-inducing signaling complex assembly / intermediate filament cytoskeleton organization / type B pancreatic cell proliferation / regulation of Rho protein signal transduction / SHOC2 M1731 mutant abolishes MRAS complex function / Gain-of-function MRAS complexes activate RAF signaling / Rap1 signalling / regulation of cell motility / insulin secretion involved in cellular response to glucose stimulus / forebrain astrocyte development ...death-inducing signaling complex assembly / intermediate filament cytoskeleton organization / type B pancreatic cell proliferation / regulation of Rho protein signal transduction / SHOC2 M1731 mutant abolishes MRAS complex function / Gain-of-function MRAS complexes activate RAF signaling / Rap1 signalling / regulation of cell motility / insulin secretion involved in cellular response to glucose stimulus / forebrain astrocyte development / Negative feedback regulation of MAPK pathway / negative regulation of epithelial cell differentiation / regulation of synaptic transmission, GABAergic / epithelial tube branching involved in lung morphogenesis / type I pneumocyte differentiation / IFNG signaling activates MAPKs / GP1b-IX-V activation signalling / ERBB2-ERBB3 signaling pathway / Rac protein signal transduction / regulation of cell differentiation / face development / skeletal muscle cell differentiation / pseudopodium / positive regulation of Rac protein signal transduction / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / somatic stem cell population maintenance / thyroid gland development / neurotrophin TRK receptor signaling pathway / RAS signaling downstream of NF1 loss-of-function variants / RUNX3 regulates p14-ARF / SOS-mediated signalling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / extrinsic apoptotic signaling pathway via death domain receptors / SHC1 events in ERBB4 signaling / MAP kinase kinase kinase activity / Signalling to RAS / SHC-related events triggered by IGF1R / glial cell proliferation / Activated NTRK2 signals through FRS2 and FRS3 / negative regulation of protein-containing complex assembly / Estrogen-stimulated signaling through PRKCZ / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / Schwann cell development / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / SHC-mediated cascade:FGFR2 / PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases / type II interferon-mediated signaling pathway / SHC-mediated cascade:FGFR4 / Signaling by FGFR4 in disease / SHC-mediated cascade:FGFR1 / Erythropoietin activates RAS / negative regulation of extrinsic apoptotic signaling pathway via death domain receptors / protein-membrane adaptor activity / FRS-mediated FGFR3 signaling / Signaling by CSF3 (G-CSF) / Signaling by FLT3 ITD and TKD mutants / positive regulation of glial cell proliferation / homeostasis of number of cells within a tissue / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / Signaling by FGFR3 in disease / p38MAPK events / Tie2 Signaling / FRS-mediated FGFR1 signaling / Signaling by FGFR2 in disease / striated muscle cell differentiation / GRB2 events in EGFR signaling / SHC1 events in EGFR signaling / activation of adenylate cyclase activity / response to muscle stretch / EGFR Transactivation by Gastrin / Signaling by FLT3 fusion proteins / FLT3 Signaling / myelination / Ras activation upon Ca2+ influx through NMDA receptor / Signaling by FGFR1 in disease / GRB2 events in ERBB2 signaling / NCAM signaling for neurite out-growth / CD209 (DC-SIGN) signaling / SHC1 events in ERBB2 signaling / Downstream signal transduction / Constitutive Signaling by Overexpressed ERBB2 / Insulin receptor signalling cascade / insulin-like growth factor receptor signaling pathway / small monomeric GTPase / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / thymus development / G protein activity / VEGFR2 mediated cell proliferation / FCERI mediated MAPK activation / Signaling by ERBB2 TMD/JMD mutants / RAF activation / regulation of long-term neuronal synaptic plasticity / Signaling by high-kinase activity BRAF mutants / wound healing
Similarity search - Function
Raf-like Ras-binding domain / Raf-like Ras-binding / Ras-binding domain (RBD) profile. / Raf-like Ras-binding domain / Diacylglycerol/phorbol-ester binding / Phorbol esters/diacylglycerol binding domain (C1 domain) / Zinc finger phorbol-ester/DAG-type signature. / Zinc finger phorbol-ester/DAG-type profile. / Protein kinase C conserved region 1 (C1) domains (Cysteine-rich domains) / Protein kinase C-like, phorbol ester/diacylglycerol-binding domain ...Raf-like Ras-binding domain / Raf-like Ras-binding / Ras-binding domain (RBD) profile. / Raf-like Ras-binding domain / Diacylglycerol/phorbol-ester binding / Phorbol esters/diacylglycerol binding domain (C1 domain) / Zinc finger phorbol-ester/DAG-type signature. / Zinc finger phorbol-ester/DAG-type profile. / Protein kinase C conserved region 1 (C1) domains (Cysteine-rich domains) / Protein kinase C-like, phorbol ester/diacylglycerol-binding domain / C1-like domain superfamily / Small GTPase, Ras-type / small GTPase Ras family profile. / Ran (Ras-related nuclear proteins) /TC4 subfamily of small GTPases / Rho (Ras homology) subfamily of Ras-like small GTPases / Ras subfamily of RAS small GTPases / Small GTPase / Ras family / Rab subfamily of small GTPases / Small GTP-binding protein domain / Ubiquitin-like domain superfamily / Serine/threonine-protein kinase, active site / Serine/Threonine protein kinases active-site signature. / Protein kinase domain / Serine/Threonine protein kinases, catalytic domain / Protein kinase, ATP binding site / Protein kinases ATP-binding region signature. / Protein kinase domain profile. / Protein kinase domain / Protein kinase-like domain superfamily / P-loop containing nucleoside triphosphate hydrolase
Similarity search - Domain/homology
PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER / GTPase KRas / RAF proto-oncogene serine/threonine-protein kinase
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 1.65 Å
AuthorsWhitley, M.J. / Simanshu, D.K.
Funding support United States, 1items
OrganizationGrant numberCountry
National Institutes of Health/National Cancer Institute (NIH/NCI)HHSN261200800001E United States
CitationJournal: Sci Adv / Year: 2024
Title: Comparative analysis of KRAS4a and KRAS4b splice variants reveals distinctive structural and functional properties.
Authors: Whitley, M.J. / Tran, T.H. / Rigby, M. / Yi, M. / Dharmaiah, S. / Waybright, T.J. / Ramakrishnan, N. / Perkins, S. / Taylor, T. / Messing, S. / Esposito, D. / Nissley, D.V. / McCormick, F. / ...Authors: Whitley, M.J. / Tran, T.H. / Rigby, M. / Yi, M. / Dharmaiah, S. / Waybright, T.J. / Ramakrishnan, N. / Perkins, S. / Taylor, T. / Messing, S. / Esposito, D. / Nissley, D.V. / McCormick, F. / Stephen, A.G. / Turbyville, T. / Cornilescu, G. / Simanshu, D.K.
History
DepositionJun 19, 2023Deposition site: RCSB / Processing site: RCSB
Revision 1.0Feb 14, 2024Provider: repository / Type: Initial release
Revision 1.1Feb 28, 2024Group: Database references / Category: citation / citation_author
Item: _citation.journal_volume / _citation.page_first ..._citation.journal_volume / _citation.page_first / _citation.page_last / _citation.pdbx_database_id_PubMed / _citation.title

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: GTPase KRas
B: RAF proto-oncogene serine/threonine-protein kinase
hetero molecules


Theoretical massNumber of molelcules
Total (without water)30,0794
Polymers29,5332
Non-polymers5472
Water3,549197
1


  • Idetical with deposited unit
  • defined by author
  • Evidence: gel filtration
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Unit cell
Length a, b, c (Å)53.371, 37.703, 70.876
Angle α, β, γ (deg.)90.000, 101.670, 90.000
Int Tables number4
Space group name H-MP1211

-
Components

#1: Protein GTPase KRas / K-Ras 2 / Ki-Ras / c-K-ras / c-Ki-ras


Mass: 20426.123 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: KRAS, KRAS2, RASK2 / Production host: Escherichia coli (E. coli) / References: UniProt: P01116, small monomeric GTPase
#2: Protein RAF proto-oncogene serine/threonine-protein kinase / Proto-oncogene c-RAF / cRaf / Raf-1


Mass: 9106.649 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: RAF1, RAF / Production host: Escherichia coli (E. coli)
References: UniProt: P04049, non-specific serine/threonine protein kinase
#3: Chemical ChemComp-MG / MAGNESIUM ION


Mass: 24.305 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: Mg
#4: Chemical ChemComp-GNP / PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER


Mass: 522.196 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: C10H17N6O13P3
Comment: GppNHp, GMPPNP, energy-carrying molecule analogue*YM
#5: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 197 / Source method: isolated from a natural source / Formula: H2O
Has ligand of interestN

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.48 Å3/Da / Density % sol: 50.44 %
Crystal growTemperature: 293 K / Method: vapor diffusion, sitting drop / Details: 0.15 M DL-malic acid (pH 7.0), 20% PEG 3350

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: APS / Beamline: 24-ID-E / Wavelength: 0.9791 Å
DetectorType: DECTRIS EIGER X 16M / Detector: PIXEL / Date: Apr 23, 2022
RadiationMonochromator: Si(220) / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.9791 Å / Relative weight: 1
ReflectionResolution: 1.65→46.52 Å / Num. obs: 31826 / % possible obs: 94.6 % / Redundancy: 3.3 % / Biso Wilson estimate: 25.2 Å2 / CC1/2: 0.999 / Rmerge(I) obs: 0.043 / Rrim(I) all: 0.051 / Net I/σ(I): 15.4
Reflection shell
Resolution (Å)Rmerge(I) obsNum. unique obsCC1/2Rrim(I) allDiffraction-ID
1.65-1.750.56441280.7090.7251
1.75-1.870.39149660.8840.4691
1.87-2.020.21446560.9670.2531
2.02-2.210.12242920.9860.1461
2.21-2.470.07438570.9940.0881
2.47-2.850.05134560.9960.061
2.85-3.490.03228830.9980.0381
3.49-4.930.02522790.9990.031
4.93-46.520.0213100.9990.0241

-
Processing

Software
NameVersionClassification
XDSdata reduction
XDSdata scaling
PHASERphasing
PHENIX1.20.1_4487refinement
PDB_EXTRACT3.28data extraction
RefinementMethod to determine structure: MOLECULAR REPLACEMENT / Resolution: 1.65→46.52 Å / SU ML: 0.23 / Cross valid method: THROUGHOUT / σ(F): 1.36 / Phase error: 23.36 / Stereochemistry target values: ML
RfactorNum. reflection% reflection
Rfree0.1958 1511 4.75 %
Rwork0.1728 30302 -
obs0.1739 31813 94.65 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.1 Å / Solvent model: FLAT BULK SOLVENT MODEL
Displacement parametersBiso max: 148.55 Å2 / Biso mean: 42.6345 Å2 / Biso min: 15.82 Å2
Refinement stepCycle: final / Resolution: 1.65→46.52 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms1907 0 46 197 2150
Biso mean--26.49 40.32 -
Num. residues----238
Refine LS restraints
Refine-IDTypeDev idealNumber
X-RAY DIFFRACTIONf_bond_d0.0032007
X-RAY DIFFRACTIONf_angle_d0.7092717
X-RAY DIFFRACTIONf_chiral_restr0.052307
X-RAY DIFFRACTIONf_plane_restr0.006346
X-RAY DIFFRACTIONf_dihedral_angle_d13.238768
LS refinement shell

Refine-ID: X-RAY DIFFRACTION / Rfactor Rfree error: 0 / Total num. of bins used: 11

Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkNum. reflection all% reflection obs (%)
1.65-1.70.43341020.39062044214671
1.7-1.760.33491240.31042490261486
1.76-1.840.24451400.23762819295998
1.84-1.920.2541440.19632894303899
1.92-2.020.20181410.18282823296499
2.02-2.150.22121420.18272844298698
2.15-2.310.17391410.15672833297498
2.31-2.540.21421440.15792875301999
2.54-2.910.20051420.17242860300298
2.91-3.670.19691430.15762862300597
3.67-46.520.15981480.15882958310698
Refinement TLS params.

Method: refined / Refine-ID: X-RAY DIFFRACTION

IDL112)L122)L132)L222)L232)L332)S11 (Å °)S12 (Å °)S13 (Å °)S21 (Å °)S22 (Å °)S23 (Å °)S31 (Å °)S32 (Å °)S33 (Å °)T112)T122)T132)T222)T232)T332)Origin x (Å)Origin y (Å)Origin z (Å)
12.7795-0.74960.76733.7081-0.98932.6472-0.0141-0.1082-0.15110.09120.09550.2890.1627-0.1964-0.08840.1819-0.00350.03370.1882-0.0030.18799.93892.801310.9413
28.2291-5.15021.15255.7022-0.56735.7483-0.2233-0.72450.30590.15230.04920.5506-0.1459-0.9822-0.29470.12-0.0232-0.04470.4609-0.01870.4334-3.44124.91915.4651
31.5195-0.66-0.74775.081-0.04221.26380.0251-0.07810.04650.37090.04350.2811-0.1260.0028-0.08350.2286-0.00580.01690.2332-0.01630.203511.96657.250915.1041
44.62231.85542.63773.04571.33785.4944-0.1340.13320.31020.07660.08530.0771-0.33920.22680.05210.2086-0.00690.01040.19260.00340.222718.609816.21454.575
54.10820.392-0.73632.6141-0.30411.1646-0.07780.3213-0.122-0.21930.0558-0.1035-0.11560.0530.0360.20640.0003-0.00790.2306-0.00660.19917.09998.3817-3.0088
64.7837-2.07121.3472.8371-0.93932.14460.0941-0.0259-0.0346-0.0383-0.014-0.02050.15980.0778-0.09980.1581-0.0065-0.00320.16790.00070.14518.1806-1.66656.1258
77.5696-1.69630.83137.3902-3.48381.65910.2179-0.11661.36830.58090.1584-0.678-1.114-0.2595-0.20610.79460.13520.16330.4047-0.06110.55950.98416.368925.0845
84.1989-0.5568-0.79839.630.6014.3671-0.0399-0.5432-0.00870.73370.2239-0.34260.09930.0847-0.16510.40180.02310.06030.3457-0.00720.25065.41444.267424.4237
92.69861.89172.00569.090.1332.6391-0.58370.62650.78810.28330.44561.4191-0.4547-1.02790.07480.68890.270.17540.58590.13730.5968-4.773416.606221.3892
103.7324-2.7756-3.75547.74923.50394.0332-0.03510.3035-0.22260.3376-0.15961.27380.0706-1.23430.03020.4109-0.00330.09970.5818-0.02220.5151-5.86814.915920.2055
116.58250.50032.02187.69654.38353.4287-0.7683-0.5531-0.89150.1220.04240.57420.9915-1.12190.70690.9104-0.05110.34710.76810.07330.5729-5.40322.030129.8359
122.54050.19141.50644.88530.22354.82170.1563-0.8518-0.18250.8428-0.15721.0754-0.264-0.77240.32220.89890.14690.33720.8857-0.05520.6372-7.81019.54532.3884
138.44770.49260.1523.573-3.62273.7239-0.5438-0.89530.33380.7399-0.4628-0.46920.3463-0.16390.95430.82960.05440.00670.56280.0070.3624-0.49986.614830.8087
Refinement TLS group
IDRefine-IDRefine TLS-IDSelection detailsAuth asym-IDAuth seq-ID
1X-RAY DIFFRACTION1(chain A and resid 1:26)A1 - 26
2X-RAY DIFFRACTION2(chain A and resid 27:31)A27 - 31
3X-RAY DIFFRACTION3(chain A and resid 32:79)A32 - 79
4X-RAY DIFFRACTION4(chain A and resid 80:106)A80 - 106
5X-RAY DIFFRACTION5(chain A and resid 107:145)A107 - 145
6X-RAY DIFFRACTION6(chain A and resid 146:170)A146 - 170
7X-RAY DIFFRACTION7(chain B and resid 56:59)B56 - 59
8X-RAY DIFFRACTION8(chain B and resid 60:69)B60 - 69
9X-RAY DIFFRACTION9(chain B and resid 70:75)B70 - 75
10X-RAY DIFFRACTION10(chain B and resid 76:91)B76 - 91
11X-RAY DIFFRACTION11(chain B and resid 92:101)B92 - 101
12X-RAY DIFFRACTION12(chain B and resid 102:121)B102 - 121
13X-RAY DIFFRACTION13(chain B and resid 122:131)B122 - 131

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbjlvh1.pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more